Document is current

Article History

First Online: 28 June 2019

Compliance with Ethical Standards

:

: GlaxoSmithKline Biologicals SA funded this study (GSK study identifier: HO-15-15891) and was involved in all stages of study conduct, including analysis of the data. GlaxoSmithKline Biologicals SA also covered all costs associated with the development and publication of this manuscript.

: AMG, DVO, RW, LV and DC are employees of the GSK group of companies and DC holds shares in the GSK group of companies. MS and MG are employees of Evidera, a consulting firm that received fees from the GSK group of companies to conduct of these analyses. During the conduct of this study, HJ was also an employee of Evidera.

: Shingrix is a trademark of the GSK group of companies. Zostavax is a trademark from Merck Sharp & Dohme Corp.

: AM, DVO, RW, MS and DC participated to the conception of the analysis and adaptation of the model. All authors were involved in the data collection. AM, DVO, MS, HJ and DC performed the analysis. AM, DVO, RW, MS, HJ, LV and DC participated to the interpretation of the data. All authors had full access to the data, reviewed the manuscript and approved the final version of the paper for submission.

: GSK makes available anonymized individual participant data and associated documents from interventional clinical studies which evaluate medicines, upon approval of proposals submitted to . To access data for other types of GSK sponsored research, for study documents without patient-level data and for clinical studies not listed, please submit an enquiry via the website.